GLOBAL BIOENERGIES sets foot in Asia

Regulatory News:

Global Bioenergies (NYSE Alternext Paris: ALGBE), an industrial biology company developing sustainable routes to light olefins, announces today having launched its activities in Hong Kong to prospect industrial and financial opportunities in Asia.

Jean-Baptiste Barbaroux, Head of Corporate Development of Global Bioenergies, who recently relocated to Hong Kong, declares: "The premise to our Asian network had been initiated and managed from France. Our presence on the ground, in one of Asia’s major financial hubs, will be instrumental in strengthening and broadening this network.”

Marc Delcourt, CEO of Global Bioenergies, adds: "Global Bioenergies has previously established activities in the United States and Germany. With this new presence in Asia, Global Bioenergies fully deserves its name, and extends itself to the world’s most dynamic region.”

About GLOBAL BIOENERGIES

Global Bioenergies is one of the few companies worldwide, and the only one in Europe, that is developing a process to convert renewable resources into hydrocarbons through fermentation. The Company initially focused its efforts on the production of isobutene, one of the most important petrochemical building blocks that can be converted into fuels, plastics, organic glass and elastomers. Global Bioenergies continues to improve the yield of its process and prepares the phase dedicated to pilot testing. The company recently replicated this success to propylene and butadiene and is also looking to continue with other members of the gaseous olefins family, key molecules at the heart of petrochemical industry. Global Bioenergies is listed on NYSE Alternext Paris (FR0011052257 – ALGBE).

Should you like to be kept informed, subscribe to our news feed on
www.global-bioenergies.com